These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 12727582)

  • 1. Familial hyperkalemic hypertension: phenotypic analysis in a large family with the WNK1 deletion mutation.
    Achard JM; Warnock DG; Disse-Nicodème S; Fiquet-Kempf B; Corvol P; Fournier A; Jeunemaitre X
    Am J Med; 2003 Apr; 114(6):495-8. PubMed ID: 12727582
    [No Abstract]   [Full Text] [Related]  

  • 2. Human hypertension caused by mutations in WNK kinases.
    Hollenberg NK
    Curr Hypertens Rep; 2002 Aug; 4(4):267. PubMed ID: 12166403
    [No Abstract]   [Full Text] [Related]  

  • 3. WNK1-related Familial Hyperkalemic Hypertension results from an increased expression of L-WNK1 specifically in the distal nephron.
    Vidal-Petiot E; Elvira-Matelot E; Mutig K; Soukaseum C; Baudrie V; Wu S; Cheval L; Huc E; Cambillau M; Bachmann S; Doucet A; Jeunemaitre X; Hadchouel J
    Proc Natl Acad Sci U S A; 2013 Aug; 110(35):14366-71. PubMed ID: 23940364
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of 108 SNPs in TSC, WNK1, and WNK4 and their association with hypertension in a Japanese general population.
    Kokubo Y; Kamide K; Inamoto N; Tanaka C; Banno M; Takiuchi S; Kawano Y; Tomoike H; Miyata T
    J Hum Genet; 2004; 49(9):507-515. PubMed ID: 15309683
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human hypertension caused by mutations in WNK kinases.
    Wilson FH; Disse-Nicodème S; Choate KA; Ishikawa K; Nelson-Williams C; Desitter I; Gunel M; Milford DV; Lipkin GW; Achard JM; Feely MP; Dussol B; Berland Y; Unwin RJ; Mayan H; Simon DB; Farfel Z; Jeunemaitre X; Lifton RP
    Science; 2001 Aug; 293(5532):1107-12. PubMed ID: 11498583
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Familial hyperkalemic hypertension.
    Hadchouel J; Delaloy C; Fauré S; Achard JM; Jeunemaitre X
    J Am Soc Nephrol; 2006 Jan; 17(1):208-17. PubMed ID: 16221868
    [No Abstract]   [Full Text] [Related]  

  • 7. Association of blood pressure with genetic variation in WNK kinases in a white European population.
    Zhang H; Staessen JA
    Circulation; 2005 Nov; 112(22):3371-2. PubMed ID: 16316962
    [No Abstract]   [Full Text] [Related]  

  • 8. Pseudohypoaldosteronism Type II: A Young Girl Presented with Hypertension, Hyperkalemia and Metabolic Acidosis.
    Sethar GH; Almoghawi A; Khan N; Altourah W; Ashour NM
    J Coll Physicians Surg Pak; 2018 Mar; 28(3):S21-S22. PubMed ID: 29482694
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of with-no-lysine [K] kinases in the pathogenesis of Gordon's syndrome.
    Xie J; Craig L; Cobb MH; Huang CL
    Pediatr Nephrol; 2006 Sep; 21(9):1231-6. PubMed ID: 16683163
    [TBL] [Abstract][Full Text] [Related]  

  • 10. WNKs: protein kinases with a unique kinase domain.
    Huang CL; Cha SK; Wang HR; Xie J; Cobb MH
    Exp Mol Med; 2007 Oct; 39(5):565-73. PubMed ID: 18059132
    [TBL] [Abstract][Full Text] [Related]  

  • 11. WNK kinases, distal tubular ion handling and hypertension.
    Faure S; Delaloy C; Leprivey V; Hadchouel J; Warnock DG; Jeunemaitre X; Achard JM
    Nephrol Dial Transplant; 2003 Dec; 18(12):2463-7. PubMed ID: 14605263
    [No Abstract]   [Full Text] [Related]  

  • 12. Familial hyperkalemic hypertension (Gordon syndrome): evidence for phenotypic variability in a study of 7 families.
    Disse-Nicodème S; Achard JM; Potier J; Delahousse M; Fiquet-Kempf B; Stern N; Blanchard A; Guilbaud JC; Niaudet P; Chauveau D; Dussol B; Berland Y; Dequiedt P; Ader JL; Paillard M; Grünfeld JP; Fournier A; Corvol P; Jeunemaitre X
    Adv Nephrol Necker Hosp; 2001; 31():55-68. PubMed ID: 11692471
    [No Abstract]   [Full Text] [Related]  

  • 13. Deletion of WNK1 first intron results in misregulation of both isoforms in renal and extrarenal tissues.
    Delaloy C; Elvira-Matelot E; Clemessy M; Zhou XO; Imbert-Teboul M; Houot AM; Jeunemaitre X; Hadchouel J
    Hypertension; 2008 Dec; 52(6):1149-54. PubMed ID: 18955660
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathogenesis of pseudohypoaldosteronism type 2 by WNK1 mutations.
    Bergaya S; Vidal-Petiot E; Jeunemaitre X; Hadchouel J
    Curr Opin Nephrol Hypertens; 2012 Jan; 21(1):39-45. PubMed ID: 22080857
    [TBL] [Abstract][Full Text] [Related]  

  • 15. WNK kinases, renal ion transport and hypertension.
    San-Cristobal P; de los Heros P; Ponce-Coria J; Moreno E; Gamba G
    Am J Nephrol; 2008; 28(5):860-70. PubMed ID: 18547946
    [TBL] [Abstract][Full Text] [Related]  

  • 16. WNK4 is indispensable for the pathogenesis of pseudohypoaldosteronism type II caused by mutant KLHL3.
    Susa K; Sohara E; Takahashi D; Okado T; Rai T; Uchida S
    Biochem Biophys Res Commun; 2017 Sep; 491(3):727-732. PubMed ID: 28743496
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pseudohypoaldosteronism type 2 presenting with hypertension and hyperkalaemia due to a novel mutation in the WNK4 gene.
    Brooks AM; Owens M; Sayer JA; Salzmann M; Ellard S; Vaidya B
    QJM; 2012 Aug; 105(8):791-4. PubMed ID: 21764813
    [No Abstract]   [Full Text] [Related]  

  • 18. Impaired degradation of WNK1 and WNK4 kinases causes PHAII in mutant KLHL3 knock-in mice.
    Susa K; Sohara E; Rai T; Zeniya M; Mori Y; Mori T; Chiga M; Nomura N; Nishida H; Takahashi D; Isobe K; Inoue Y; Takeishi K; Takeda N; Sasaki S; Uchida S
    Hum Mol Genet; 2014 Oct; 23(19):5052-60. PubMed ID: 24821705
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hyperkalemic hypertension-associated cullin 3 promotes WNK signaling by degrading KLHL3.
    McCormick JA; Yang CL; Zhang C; Davidge B; Blankenstein KI; Terker AS; Yarbrough B; Meermeier NP; Park HJ; McCully B; West M; Borschewski A; Himmerkus N; Bleich M; Bachmann S; Mutig K; Argaiz ER; Gamba G; Singer JD; Ellison DH
    J Clin Invest; 2014 Nov; 124(11):4723-36. PubMed ID: 25250572
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanisms of type I and type II pseudohypoaldosteronism.
    Furgeson SB; Linas S
    J Am Soc Nephrol; 2010 Nov; 21(11):1842-5. PubMed ID: 20829405
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.